В последнее десятилетие во всем мире отмечен значительный прогресс вспомогательных репродуктивных технологий, что выразилось в росте общего числа процедур и их доступности. Однако современной клинической задачей остается повышение эффективности и безопасности репродуктивных технологий. Оптимальная структура и рецептивность эндометрия в период имплантации хорошо известны как важнейшие факторы успеха вспомогательных репродуктивных технологий. На этапе подготовки к беременности пациенток с тонким эндометрием и другой патологией успешно используются трофические факторы с целью улучшения параметров рецептивности ткани.
ART progress was tremendous in the last decade with the growth of total quantity and availability of procedures. However current clinical purpose remains an improvement of efficiency and safety of reproductive technologies. The health condition of endometrium and optimal receptivity in time of implantation are well known as crucial factor of ART success. Clinical application of trophic factors can be used in pregnancy preparation management in patients with thin endometrium and any pathology to improve tissue receptivity.
1. РАРЧ. Национальный Российский Регистр ВРТ. www.rahr.ru.
2. CDC ART National Summary Report. www.cdc.gov.
3. ESHRE. Newsletters. www.eshre.eu.
4. Penzias AS. Recurrent IVF failure: other factors. Fertil Steril 2012; 97 (5): 1033–8.
5. Revel A. Defective endometrial receptivity. Fertil Steril 2012; 97 (5): 1028–32.
6. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol 2008; 20 (3): 221–8.
7. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril 2012; 97 (5): 1039–43.
8. Сухих Г.Т., Шуршалина А.В. Хронический эндометрит. М.: ГЭОТАР-Медиа, 2010.
9. Chronic endometritis is a frequent finding in women with recurrent implantation failures after in vitro fertilization. Fertil Steril 2010; 93 (2): 437–41.
10. Dekel N, Gnainsky Y, Granot I, Mor G. Inflammation and implantation. Am J Reprod Immunol 2010; 63 (1): 17–21.
11. Granot I, Gnainsky Y, Dekel N. Endometrial inflammation and effect on implantation improvement and pregnancy outcome. Reproduction 2012; 144 (6): 661–8.
12. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet 2012; 29 (11): 1227–39.
13. Horne AW, Critchley HO. The effect of uterine fibroids on embryo implantation. Semin Reprod Med 2007; 25 (6): 483–9.
14. Физиология человека. Под ред. Р.Шмидта, Г.Тевса. Пер. с англ. Т. 3–4. М., 1985.
15. Boudjenah R, Molina-Gomes D, Wainer R. The vascular endothelial growth factor (VEGF) +405 G/C polymorphism and its relationship with recurrent implantation failure in women in an IVF programme with ICSI. J Assist Reprod Genet 2012; 29 (12): 1415–20.
16. Bourdiec A, Shao R, Rao CV. Human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod 2012; 87 (3): 66.
17. Check JH. The importance of sonographic endometrial parameters in influencing success following embryo transfer in the modern era and therapeutic options: the importance of late proliferative phase endometrial thickness. Clin Exp Obstet Gynecol 2011; 38 (3): 197–200.
18. Neeta S, Bahadur M, Mittal S. Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: A prospective clinical study from a tertiary care unit. J Hum Reprod Sci 2011; 4 (1): 29–33.
19. Salamonsen LA, Edgell T, Rombauts LJ. Proteomics of the human endometrium and uterine fluid: a pathway to biomarker discovery. Fertil Steril 2012; 6 (12): 2192–9.
20. Vilella F, Ramirez LB, Simon C. Lipidomics as an emerging tool to predict endometrial receptivity. Fertil Steril 2013. pii: S0015-0282(12)02535-6.
21. Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012; 6: CD005996.
22. Gargett CE, Healy DL. Generating receptive endometrium in Asherman's syndrome. J Hum Reprod Sci 2011; 4 (1): 49–52.
23. Gleicher N, Kim A, Michaeli T. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod 2013; 1: 172–7.
24. Wang XW, Lin XY, Bi YH, Han JQ. Effect of actovegin on intestinal mucosa and expression of bcl-2/bax genes in rats with acute radiation enteritis. Zhonghua Zhong Liu Za Zhi 2009; 31 (10): 742–5.
________________________________________________
1. РАРЧ. Национальный Российский Регистр ВРТ. www.rahr.ru.
2. CDC ART National Summary Report. www.cdc.gov.
3. ESHRE. Newsletters. www.eshre.eu.
4. Penzias AS. Recurrent IVF failure: other factors. Fertil Steril 2012; 97 (5): 1033–8.
5. Revel A. Defective endometrial receptivity. Fertil Steril 2012; 97 (5): 1028–32.
6. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol 2008; 20 (3): 221–8.
7. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril 2012; 97 (5): 1039–43.
8. Сухих Г.Т., Шуршалина А.В. Хронический эндометрит. М.: ГЭОТАР-Медиа, 2010.
9. Chronic endometritis is a frequent finding in women with recurrent implantation failures after in vitro fertilization. Fertil Steril 2010; 93 (2): 437–41.
10. Dekel N, Gnainsky Y, Granot I, Mor G. Inflammation and implantation. Am J Reprod Immunol 2010; 63 (1): 17–21.
11. Granot I, Gnainsky Y, Dekel N. Endometrial inflammation and effect on implantation improvement and pregnancy outcome. Reproduction 2012; 144 (6): 661–8.
12. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet 2012; 29 (11): 1227–39.
13. Horne AW, Critchley HO. The effect of uterine fibroids on embryo implantation. Semin Reprod Med 2007; 25 (6): 483–9.
14. Физиология человека. Под ред. Р.Шмидта, Г.Тевса. Пер. с англ. Т. 3–4. М., 1985.
15. Boudjenah R, Molina-Gomes D, Wainer R. The vascular endothelial growth factor (VEGF) +405 G/C polymorphism and its relationship with recurrent implantation failure in women in an IVF programme with ICSI. J Assist Reprod Genet 2012; 29 (12): 1415–20.
16. Bourdiec A, Shao R, Rao CV. Human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod 2012; 87 (3): 66.
17. Check JH. The importance of sonographic endometrial parameters in influencing success following embryo transfer in the modern era and therapeutic options: the importance of late proliferative phase endometrial thickness. Clin Exp Obstet Gynecol 2011; 38 (3): 197–200.
18. Neeta S, Bahadur M, Mittal S. Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: A prospective clinical study from a tertiary care unit. J Hum Reprod Sci 2011; 4 (1): 29–33.
19. Salamonsen LA, Edgell T, Rombauts LJ. Proteomics of the human endometrium and uterine fluid: a pathway to biomarker discovery. Fertil Steril 2012; 6 (12): 2192–9.
20. Vilella F, Ramirez LB, Simon C. Lipidomics as an emerging tool to predict endometrial receptivity. Fertil Steril 2013. pii: S0015-0282(12)02535-6.
21. Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012; 6: CD005996.
22. Gargett CE, Healy DL. Generating receptive endometrium in Asherman's syndrome. J Hum Reprod Sci 2011; 4 (1): 49–52.
23. Gleicher N, Kim A, Michaeli T. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod 2013; 1: 172–7.
24. Wang XW, Lin XY, Bi YH, Han JQ. Effect of actovegin on intestinal mucosa and expression of bcl-2/bax genes in rats with acute radiation enteritis. Zhonghua Zhong Liu Za Zhi 2009; 31 (10): 742–5.